Literature DB >> 34933332

Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS report.

Nora Balas1, Lindsey Hageman1, Jessica Wu1, Liton Francisco1, Elizabeth Schlichting1, Alysia Bosworth2, Hok Sreng Te3, F Lennie Wong2, Wendy Landier1, Donna Salzman1, Daniel J Weisdorf3, Stephen J Forman2, Mukta Arora3, Saro H Armenian3, Smita Bhatia1.   

Abstract

We examine the impact of conditioning intensity (low intensity: nonmyeloablative/reduced intensity vs high intensity: myeloablative) and total body irradiation (TBI) on the probability of live birth after blood or marrow transplantation (BMT). Study participants were drawn from the BMT Survivor Study (BMTSS) and included 1607 transplant survivors between 1974 and 2014 at age ≤45 years, with survival ≥2 years post-BMT and age at study ≥18 years. Closest-age, same-sex biologic siblings (n = 172) were 1:1 matched with 172 survivors. Survivors and siblings self-reported information on sociodemographic, chronic health conditions, and pregnancies. Within survivor analysis: the association between the primary exposure variable (no TBI/low-intensity conditioning; 200 to 800 cGy TBI/low-intensity conditioning; no TBI/high-intensity conditioning; >800 cGy TBI/high-intensity conditioning) and the odds of no post-BMT live birth were examined using multivariable logistic regression, adjusting for clinical and demographic variables. Median age at BMT was 31 years (IQR, 0 to 45), and median length of follow-up was 14.3 years (IQR, 2.4 to 41.4); 39.3% were autologous BMT recipients, and 46.6% were female. Overall, 120 (8.7%) survivors reported post-BMT live births. Receipt of >800 cGy TBI/high-intensity conditioning (odds ratio [OR], 3.7; 95% CI, 1.9-7.0; ref: no TBI/low-intensity conditioning) was associated with higher odds of reporting no live birth post-BMT. In contrast, 200 to 800 cGy TBI/low-intensity conditioning (OR, 1.3; 95% CI, 0.5-3.3), and no TBI/high-intensity conditioning (OR, 0.9; 95% CI, 0.5-1.7) were at similar risk of reporting post-BMT live birth as no TBI/low-intensity conditioning. Comparison with biologic siblings: Using conditional logistic regression, we found that BMT survivors were more likely to report no live birth (OR, 2.0; 95% CI, 1.2-3.3) compared with siblings. These findings could inform conditioning intensity options for patients wishing to preserve fertility post-BMT.
© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34933332      PMCID: PMC9043940          DOI: 10.1182/bloodadvances.2021006300

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  17 in total

1.  Positive reproductive family history for spontaneous abortion: predictor for recurrent miscarriage in young couples.

Authors:  Silvana Miskovic; Vida Culic; Pasko Konjevoda; Jasminka Pavelic
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2012-01-26       Impact factor: 2.435

2.  Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Nathalie Forgeard; Matthieu Jestin; Dominique Vexiau; Florian Chevillon; Elise Ricadat; Régis Peffault de Latour; Marie Robin; Flore Sicre de Fontbrune; Aliénor Xhaard; David Michonneau; Nicolas Boissel; Catherine Poirot; Nathalie Dhédin
Journal:  Transplant Cell Ther       Date:  2021-02-06

3.  Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning.

Authors:  R Phelan; E Mann; C Napurski; T E DeFor; A Petryk; W P Miller; J E Wagner; M R Verneris; A R Smith
Journal:  Bone Marrow Transplant       Date:  2016-06-06       Impact factor: 5.483

Review 4.  Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).

Authors:  Alison W Loren; Eric Chow; David A Jacobsohn; Maria Gilleece; Joerg Halter; Sarita Joshi; Zhiwei Wang; Kathleen A Sobocinski; Vikas Gupta; Gregory A Hale; David I Marks; Edward A Stadtmauer; Jane Apperley; Jean-Yves Cahn; Harry C Schouten; Hillard M Lazarus; Bipin N Savani; Philip L McCarthy; Ann A Jakubowski; Naynesh R Kamani; Brandon Hayes-Lattin; Richard T Maziarz; Anne B Warwick; Mohamed L Sorror; Brian J Bolwell; Gerard Socié; John R Wingard; J Douglas Rizzo; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2010-07-24       Impact factor: 5.742

5.  Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey.

Authors:  N Salooja; R M Szydlo; G Socie; B Rio; R Chatterjee; P Ljungman; M T Van Lint; R Powles; G Jackson; M Hinterberger-Fischer; H J Kolb; J F Apperley
Journal:  Lancet       Date:  2001-07-28       Impact factor: 79.321

6.  Early high dose chemotherapy intensification with autologous bone marrow transplantation in lymphoma associated with retention of fertility and normal pregnancies in females. Scotland and Newcastle Lymphoma Group, UK.

Authors:  G H Jackson; A Wood; P R Taylor; A L Lennard; H Lucraft; A Heppleston; P Robinson; J Moore; S J Proctor
Journal:  Leuk Lymphoma       Date:  1997-12

7.  Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study.

Authors:  A Carter; L L Robison; L Francisco; D Smith; M Grant; K S Baker; J G Gurney; P B McGlave; D J Weisdorf; S J Forman; S Bhatia
Journal:  Bone Marrow Transplant       Date:  2006-06       Impact factor: 5.483

8.  Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors.

Authors:  Theresa Hahn; Philip L McCarthy; Anna Hassebroek; Christopher Bredeson; James L Gajewski; Gregory A Hale; Luis M Isola; Hillard M Lazarus; Stephanie J Lee; Charles F Lemaistre; Fausto Loberiza; Richard T Maziarz; J Douglas Rizzo; Steven Joffe; Susan Parsons; Navneet S Majhail
Journal:  J Clin Oncol       Date:  2013-05-28       Impact factor: 44.544

9.  Prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogenic marrow transplantation in post-menarcheal female patients.

Authors:  R Chatterjee; W Mills; M Katz; H H McGarrigle; A H Goldstone
Journal:  Bone Marrow Transplant       Date:  1994-05       Impact factor: 5.483

10.  Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation.

Authors:  J E Sanders; J Hawley; W Levy; T Gooley; C D Buckner; H J Deeg; K Doney; R Storb; K Sullivan; R Witherspoon; F R Appelbaum
Journal:  Blood       Date:  1996-04-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.